These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32419327)

  • 1. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein 2 regulates the intestinal epithelial barrier via p38 mitogen-activated protein kinase.
    Ungewiß H; Vielmuth F; Suzuki ST; Maiser A; Harz H; Leonhardt H; Kugelmann D; Schlegel N; Waschke J
    Sci Rep; 2017 Jul; 7(1):6329. PubMed ID: 28740231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's Disease.
    Spindler V; Meir M; Vigh B; Flemming S; Hütz K; Germer CT; Waschke J; Schlegel N
    Inflamm Bowel Dis; 2015 Oct; 21(10):2349-59. PubMed ID: 26115074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity.
    Schlegel N; Meir M; Heupel WM; Holthöfer B; Leube RE; Waschke J
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G774-83. PubMed ID: 20224006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury.
    Gross A; Pack LAP; Schacht GM; Kant S; Ungewiss H; Meir M; Schlegel N; Preisinger C; Boor P; Guldiken N; Krusche CA; Sellge G; Trautwein C; Waschke J; Heuser A; Leube RE; Strnad P
    Mucosal Immunol; 2018 Nov; 11(6):1630-1639. PubMed ID: 30115995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein2 Regulates Claudin2 Expression by Sequestering PI-3-Kinase in Intestinal Epithelial Cells.
    Burkard N; Meir M; Kannapin F; Otto C; Petzke M; Germer CT; Waschke J; Schlegel N
    Front Immunol; 2021; 12():756321. PubMed ID: 34659262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 5 is essential for maintenance of barrier function in mouse colon.
    Liu Y; Chidgey M; Yang VW; Bialkowska AB
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G478-G491. PubMed ID: 28864500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease.
    Meir M; Burkard N; Ungewiß H; Diefenbacher M; Flemming S; Kannapin F; Germer CT; Schweinlin M; Metzger M; Waschke J; Schlegel N
    J Clin Invest; 2019 Jun; 129(7):2824-2840. PubMed ID: 31205031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Talk about micromanaging! Role of microRNAs in intestinal barrier function.
    Al-Sadi R; Engers J; Abdulqadir R
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G170-G174. PubMed ID: 32658620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion.
    Ungewiß H; Rötzer V; Meir M; Fey C; Diefenbacher M; Schlegel N; Waschke J
    Cell Mol Life Sci; 2018 Nov; 75(22):4251-4268. PubMed ID: 29980799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
    Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
    EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of intestinal epithelial intercellular adhesion and barrier function by desmosomal cadherin desmocollin-2.
    Raya-Sandino A; Luissint AC; Kusters DHM; Narayanan V; Flemming S; Garcia-Hernandez V; Godsel LM; Green KJ; Hagen SJ; Conway DE; Parkos CA; Nusrat A
    Mol Biol Cell; 2021 Apr; 32(8):753-768. PubMed ID: 33596089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoglein 2 can undergo Ca
    Fuchs M; Kugelmann D; Schlegel N; Vielmuth F; Waschke J
    Biophys J; 2022 Apr; 121(7):1322-1335. PubMed ID: 35183520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis.
    Ebert LM; Tan LY; Johan MZ; Min KK; Cockshell MP; Parham KA; Betterman KL; Szeto P; Boyle S; Silva L; Peng A; Zhang Y; Ruszkiewicz A; Zannettino AC; Gronthos S; Koblar S; Harvey NL; Lopez AF; Shackleton M; Bonder CS
    Angiogenesis; 2016 Oct; 19(4):463-86. PubMed ID: 27338829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease.
    Petit CS; Barreau F; Besnier L; Gandille P; Riveau B; Chateau D; Roy M; Berrebi D; Svrcek M; Cardot P; Rousset M; Clair C; Thenet S
    Gastroenterology; 2012 Jul; 143(1):122-32.e15. PubMed ID: 22446194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial maturity influences EPEC-induced desmosomal alterations.
    Roxas JL; Vedantam G; Viswanathan VK
    Gut Microbes; 2019; 10(2):241-245. PubMed ID: 30183504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteropathogenic
    Roxas JL; Monasky RC; Roxas BAP; Agellon AB; Mansoor A; Kaper JB; Vedantam G; Viswanathan VK
    Cell Mol Gastroenterol Hepatol; 2018; 6(2):163-180. PubMed ID: 30003123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.